Abstract:Abstract BackgroundDepression is one of the most prevalent mental illnesses in the world today, the onset of depression is usually accompanied by neuroinflammation and neurogenic damage. Recently, G protein coupled receptor 55 (GPR55) has been associated with mood regulation as a third kind of cannabinoid receptor, and the activation of GPR55 was demonstrated recently to have a neuroprotective effect on hippocampal neurogenesis against inflammatory insult. However, its role in regulating depression and anxiety remains poorly understood.Methods10-day chronic social defeat stress (CSDS) was utilized as an animal model of depression to explore the potential antidepressant effect of GPR55 agonist and electroacupuncture (EA), a common therapy for depression in China. Several behavioral tests i.e. forced swimming test, open field test and elevated plus maze were performed to evaluate the depression- and anxiety-like behaviors in mice. Expression of GPR55, hippocampal neuroinflammation, and neurogenesis were detected using immunohistochemistry, western blot and RT-PCR. Then, the effect of a GPR55 agonist, O-1602 on depression- and anxiety-like behaviors as well as hippocampal neuroinflammation and neurogenesis was examined. Furthermore, the potential antidepressant effect of 3-week EA treatment was also evaluated in another independent experiment. In the experiment, the behaviors and hippocampal neuroinflammation and neurogenesis were also subsequently examined.ResultsAfter CSDS, the protein level of GPR55 was decreased only in susceptible mice but the mRNA expression was not significantly different in all CSDS mice. Additionally, depression- and anxiety-like behaviors are accompanied by neuroinflammation and reduced neurogenesis in the hippocampus. And the activation of GPR55 during the process of CSDS prevented the development of depression- and anxiety- like behaviors, as well as hippocampal neuroinflammation and neurogenetic damage. Similarly, EA alleviated the depression- and anxiety-like behaviors, hippocampal neuroinflammation, and neurogenetic damage as well as decreased protein level of GPR55 in hippocampus induced by CSDS.ConclusionsOur research demonstrated that activation of hippocampal GPR55 could rescue depression and anxiety phenotypes, reduce hippocampal neuroinflammation, and enhance hippocampal neurogenesis. Moreover, GPR55 might be involved in the beneficial effect of EA on depression.

The Novel Cannabinoid Receptor GPR55 Mediates Anxiolytic-Like Effects in the Medial Orbital Cortex of Mice with Acute Stress

Anxiolytic Effects of Orcinol Glucoside and Orcinol Monohydrate in Mice

11‐Ethoxyviburtinal improves chronic restraint stress‐induced anxiety‐like behaviors in gender‐specific mice via PI3K/Akt and E2/ERβ signaling pathways

The Protective Effects of GPR55 Against Hippocampal Neuroinflammation and Neurogenic Damage in CSDS Mice

Orexin 2 Receptor in the Nucleus Accumbens is Critical for the Modulation of Acute Stress-Induced Anxiety

Pleasant Odor Decreases Mouse Anxiety-like Behaviors by Regulating Hippocampal Endocannabinoid Signaling

The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice

O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment

Elucidation of the neural circuits activated by a GABAB receptor positive modulator: Relevance to anxiety

Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways

Serotonin Receptors 2A and 1A Modulate Anxiety-Like Behavior in Post-Traumatic Stress Disordered Mice.

Anxiolytic Effects of 8-O-Acetyl Shanzhiside Methylester on Acute and Chronic Anxiety via Inflammatory Response Inhibition and Excitatory/Inhibitory Transmission Imbalance

Estrogen Receptor GPR30 Exerts Anxiolytic Effects by Maintaining the Balance Between GABAergic and Glutamatergic Transmission in the Basolateral Amygdala of Ovariectomized Mice after Stress

Serotonergic transmission is required for the anxiolytic-like behavioral effects of YL-IPA08, a selective ligand targeting TSPO

Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress

Oral administration of osthole mitigates maladaptive behaviors through PPARα activation in mice subjected to repeated social defeat stress

Increased Anxiety-Like Behavior and Enhanced Synaptic Efficacy in the Amygdala of GluR5 Knockout Mice.

Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models

The delta opioid receptor agonist KNT-127 relieves innate anxiety-like behavior in mice by suppressing transmission from the prelimbic cortex to basolateral amygdala

Study of novel selective mGlu2 agonist in the temporo-ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype

Scopoletin ameliorates anxiety-like behaviors in complete Freund’s adjuvant-induced mouse model